Format

Send to

Choose Destination
FEBS Lett. 2000 Jul 28;478(1-2):1-3.

Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox.

Author information

1
Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30623, Hannover, Germany. tsikas.dimitros@mh-hannover.de

Abstract

L-Arginine, the substrate of nitric oxide (NO) synthases (NOSs), is found in the mammalian organism at concentrations by far exceeding K(M) values of these enzymes. Therefore, additional L-arginine should not enhance NO formation. In vivo, however, increasing L-arginine concentration in plasma has been shown repeatedly to increase NO production. This phenomenon has been named the L-arginine paradox; it has found no satisfactory explanation so far. In the present work, evidence for the hypothesis that the endogenous NOS inhibitors methylarginines, asymmetric dimethylarginine being the most powerful (IC(50) 1.5 microM), are responsible for the L-arginine paradox is presented.

PMID:
10922458
DOI:
10.1016/s0014-5793(00)01686-0
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center